Cargando…

Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A(1) Antagonists

[Image: see text] We herein document a large collection of 108 2-amino-4,6-disubstituted-pyrimidine derivatives as potent, structurally simple, and highly selective A(1)AR ligands. The most attractive ligands were confirmed as antagonists of the canonical cyclic adenosine monophosphate pathway, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Val, Cristina, Rodríguez-García, Carlos, Prieto-Díaz, Rubén, Crespo, Abel, Azuaje, Jhonny, Carbajales, Carlos, Majellaro, Maria, Díaz-Holguín, Alejandro, Brea, José M., Loza, Maria Isabel, Gioé-Gallo, Claudia, Contino, Marialessandra, Stefanachi, Angela, García-Mera, Xerardo, Estévez, Juan C., Gutiérrez-de-Terán, Hugo, Sotelo, Eddy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842224/ https://www.ncbi.nlm.nih.gov/pubmed/35068155 http://dx.doi.org/10.1021/acs.jmedchem.1c01636

Ejemplares similares

Exploring Non-orthosteric Interactions with a Series of Potent and Selective A(3) Antagonists
por: Miranda-Pastoriza, Darío, et al.
Publicado: (2022)

Exploring the Effect of Halogenation in a Series of Potent and Selective A(2B) Adenosine Receptor Antagonists
por: Prieto-Díaz, Rubén, et al.
Publicado: (2022)

A(2B) adenosine receptor antagonists rescue lymphocyte activity in adenosine-producing patient-derived cancer models
por: Tay, Apple Hui Min, et al.
Publicado: (2022)

Potent and Subtype-Selective Dopamine D(2) Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
por: Mallo-Abreu, Ana, et al.
Publicado: (2021)

Fluorescence based HTS-compatible ligand binding assays for dopamine D(3) receptors in baculovirus preparations and live cells
por: Tahk, Maris-Johanna, et al.
Publicado: (2023)

X‐Ray Crystallography and Free Energy Calculations Reveal the Binding Mechanism of A(2A) Adenosine Receptor Antagonists
por: Jespers, Willem, et al.
Publicado: (2020)

Development of Fluorescent Probes that Target Serotonin 5-HT(2B) Receptors
por: Azuaje, Jhonny, et al.
Publicado: (2017)

Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4′-piperidin]-1′-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques
por: Abatematteo, Francesca Serena, et al.
Publicado: (2023)

ZnO Catalyzed Efficient Synthesis of Some New 2-Substituted-4,6-diarylpyrimidines
por: Ameta, K. L., et al.
Publicado: (2012)

Multicomponent Reaction-Assisted Drug Discovery: A Time- and Cost-Effective Green Approach Speeding Up Identification and Optimization of Anticancer Drugs
por: Graziano, Giovanni, et al.
Publicado: (2023)

Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors
por: Gong, Zipeng, et al.
Publicado: (2017)

Computer-aided design of multi-target ligands at A(1)R, A(2A)R and PDE10A, key proteins in neurodegenerative diseases
por: Kalash, Leen, et al.
Publicado: (2017)

Structure-Based Design of Potent and Selective Ligands at the Four Adenosine Receptors
por: Jespers, Willem, et al.
Publicado: (2017)

Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
por: Feng, Da, et al.
Publicado: (2022)

Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors
por: Jiang, Xiangyi, et al.
Publicado: (2023)

New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer
por: Riganti, Chiara, et al.
Publicado: (2019)

(1RS,4RS,5RS)-Methyl 2-(3,5-dinitrobenzoyl)-2-oxa-3-azabicyclo[3.3.0]oct-7-ene-4-carboxylate
por: Sousa, Carlos A. D., et al.
Publicado: (2009)

Methyl 2-diphenylphosphoryloxy-2-azabicyclo[2.2.1]hept-5-ene-3-exo-carboxylate
por: Sousa, Carlos A. D., et al.
Publicado: (2008)

3-Amino-4,6-dimethylthieno[2,3-b]pyridine-2-carbonitrile
por: Zeng, Xiu-Xiu, et al.
Publicado: (2009)

Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy
por: Lei, Yuan, et al.
Publicado: (2020)

Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region
por: Zhang, Tao, et al.
Publicado: (2022)

Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
por: Contino, Marialessandra, et al.
Publicado: (2020)

Editorial: Molecular modulators of GPCRs signal transduction
por: Vrecl, Milka, et al.
Publicado: (2023)

Prediction of Multi-Target Networks of Neuroprotective Compounds with Entropy Indices and Synthesis, Assay, and Theoretical Study of New Asymmetric 1,2-Rasagiline Carbamates
por: Romero Durán, Francisco J., et al.
Publicado: (2014)

Crystal structure of 4,6-diamino-2-(methylsulfanyl)pyridine-3-carbonitrile
por: Mohamed, Shaaban K., et al.
Publicado: (2015)

2,2-Dimethyl-5-(2-nitrobenzylidene)-1,3-dioxane-4,6-dione
por: García-Álvarez, Fernando, et al.
Publicado: (2012)

Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors
por: Liu, Genyan, et al.
Publicado: (2018)

Crystal structure of racemic 2-[(β-arabinopyranosyl)sulfanyl]-4,6-diphenylpyridine-3-carbonitrile
por: Hammad, Sherif F., et al.
Publicado: (2018)

Identification of V6.51L as a selectivity hotspot in stereoselective A(2B) adenosine receptor antagonist recognition
por: Wang, Xuesong, et al.
Publicado: (2021)

Development of fluorine-substituted NH(2)-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability
por: Jin, Xin, et al.
Publicado: (2023)

Quinoxaline-2-carbonitrile
por: Fun, Hoong-Kun, et al.
Publicado: (2009)

Quinoline-2-carbonitrile
por: Loh, Wan-Sin, et al.
Publicado: (2010)

1-(3-Ethylphenyl)-4,6-dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
por: Al-Said, Mansour S., et al.
Publicado: (2012)

Crystal structure of 4,6-diamino-2-sulfanylidene-1,2-dihydropyridine-3-carbonitrile
por: Mohamed, Shaaban K., et al.
Publicado: (2014)

Editorial: The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation
por: Contino, Marialessandra, et al.
Publicado: (2017)

Novel Phthalazin-1(2H)-One Derivatives Displaying a Dithiocarbamate Moiety as Potential Anticancer Agents
por: Vila, Noemí, et al.
Publicado: (2022)

Multi-Target Directed Ligands (MTDLs) Binding the σ(1) Receptor as Promising Therapeutics: State of the Art and Perspectives
por: Abatematteo, Francesca Serena, et al.
Publicado: (2021)

Receptor-Drug Interaction: Europium Employment for Studying the Biochemical Pathway of G-Protein-Coupled Receptor Activation
por: Antonio, Colabufo Nicola, et al.
Publicado: (2007)

Small and Innovative Molecules as New Strategy to Revert MDR
por: Zinzi, Laura, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_il3aqgii6m1jsl9r0khiq103v6